This is biblical.
A woman in her eighties. Ten years into Alzheimer's. Hadn't spoken a full sentence in five years.
Takes one, 5 gram dose of psilocybin.
She slept 19 hours and woke up and spoke for hours about her life, recognized family and held real conversations. She regained bladder control after five years, walked on her own. and dressed herself. Gains held for weeks.
Welp, that happened faster than I predicted. Thought it would be end of 2027, then early 2027, but agentic traffic growing so fast that bots have now passed human traffic online for the first time in the Internet's history. https://t.co/2zX5bHdhsa
Wow, Eso era lo que se necesitaba, Gente que quiera ganar y tenga hambre de superarse 🙌🙌 Felicidades @matiasgarciard excelente Pick 👏🏾👏🏾 #PlanetaAlofoke
Carlos ganador de #PlanetaAlofoke merecido 100% cargo la casa 1 y no la ganó porque entró tarde, no ganó la casa 2 porque llegó un fenómeno como La Fruta y ahora gana el primer lugar. La constancia se premia, Carlos es sin lugar a dudas el mejor creador de contenido dominicano
1/5
I'm a cardiologist. I have spent twenty years watching cholesterol destroy arteries, trigger heart attacks, and kill people I care about.
Today, Eli Lilly presented data that may begin to end that era.
VERVE-102. A single infusion. One dose. It uses base editing to permanently turn off the PCSK9 gene in your liver.
Presented today at the European Atherosclerosis Society Congress:
88% reduction in PCSK9.
62% reduction in LDL cholesterol.
Sustained up to 18 months.
No treatment-related serious adverse events.
One infusion. Not daily pills you forget to take. Not monthly injections. One dose — and your cholesterol may stay low for the rest of your life.